Fibulin-7 in progenitor cells promotes adipose tissue fibrosis and disrupts metabolic homeostasis in obesity
Protein & Cell · 2025
DOI: 10.1093/procel/pwaf084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein & Cell, 2025. Verfasst von Hairong Yu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Shanghai Sixth People's Hospital Af…. Hauptthemen laut MEDLINE: Obesity, Extracellular Matrix Proteins, Adipose Tissue, Homeostasis. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology Major.
Abstract (Originalsprache)
Fibrosis, resulting from excess extracellular matrix (ECM) deposition, is a feature of adipose tissue (AT) dysfunction and obesity-related insulin resistance. Emerging evidence indicates that adipogenic stem and precursor cells (ASPCs) are a crucial origin of ECM proteins and possess the potential to induce AT fibrosis. Here, we employed single-cell RNA-seq and identified a unique subset of ASPCs that were closely associated with ECM function. Within this subset, we discerned a notable upregulation in the expression of fibulin-7 (FBLN7), a secreted glycoprotein, in obese mice. Similarly, in humans, FBLN7 levels exhibited an increase in visceral fat among obese individuals and demonstrated a correlation with clinical metabolic traits. Functional studies further revealed that, in response to caloric excess, ASPC-specific FBLN7 knockout mice displayed a diminished state of AT fibrosis inflammation, along with improved systemic metabolic health. Notably, the depletion of FBLN7 in ASPCs suppressed TGF-β-induced fibrogenic responses, whereas its overexpression amplified such responses. Mechanistically, FBLN7 interacted with thrombospondin-1 (TSP1) via its EGF-like calcium-binding domain, thereby enhancing the stability of the TSP1 protein. This, in turn, facilitated the conversion of latent TGF-β to its bioactive form, subsequently promoting TGFBR1/Smad signaling pathways. Furthermore, we developed an anti-FBLN7 neutralizing antibody, which could dramatically alleviate diet-induced AT fibrosis. These results suggest that FBLN7, produced by ASPCs, exerts a major influence in the development of AT fibrosis and may represent a potential target for therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai…
- Clinical Research Center, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
- Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Department of Endocrinology, Affiliated Hospital of Nantong University, Nantong 226001, China.
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 200241, China.
- Institute for Metabolic Disease, Fengxian Central Hospital Affiliated to Southern Medical University, Shanghai 201318, China.
ORCID-Profile: Cheng Hu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Noncommunicable Chronic Diseases-National Science and Technology Major
- Innovative Research Team of High-Level Local Universities in Shanghai
- Major Natural Science Project of the Scientific Research and Innovation Plan of Shanghai Municipal Commission of Education
- Shanghai Research Center for Endocrine and Metabolic Diseases
- Shanghai Rising-Star Program
- Noncommunicable Chronic Diseases—National Science and Technology Major Project
Zitieren
APA
Yu, H., Yang, F., Yan, D., Chen, W., Yao, L., Chen, H., Lai, S., Zha, J., Sun, Y., Zong, Y., Yu, J., Zhang, H., Jiang, F., Zhang, R., Zhang, J., Yan, J., & Hu, C. (2025). Fibulin-7 in progenitor cells promotes adipose tissue fibrosis and disrupts metabolic homeostasis in obesity. Protein & Cell. https://doi.org/10.1093/procel/pwaf084
Vancouver
Yu H, Yang F, Yan D, Chen W, Yao L, Chen H, et al. Fibulin-7 in progenitor cells promotes adipose tissue fibrosis and disrupts metabolic homeostasis in obesity. Protein & Cell. 2025. doi:10.1093/procel/pwaf084
BibTeX
@article{Yu2025,
author = {Yu, Hairong and Yang, Fan and Yan, Dandan and Chen, Wei and Yao, Lijun and Chen, Hongli and Lai, Siyu and Zha, Jinyin and Sun, Yi and Zong, Yicen and Yu, Jian and Zhang, Hong and Jiang, Feng and Zhang, Rong and Zhang, Jian and Yan, Jing and Hu, Cheng},
title = {Fibulin-7 in progenitor cells promotes adipose tissue fibrosis and disrupts metabolic homeostasis in obesity},
journal = {Protein & Cell},
year = {2025},
doi = {10.1093/procel/pwaf084}
}
EUVIMED